Cargando…
Delivering Glioblastoma a Kick—DGKα Inhibition as a Promising Therapeutic Strategy for GBM
SIMPLE SUMMARY: Glioblastoma is the most common and aggressive brain cancer, and there is a desperate need for new therapeutic strategies for this incurable cancer. Inhibition of Diacylglycerol kinase α provides novel direct mechanisms against glioblastoma cells, but also offers the potential to sim...
Autor principal: | Purow, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909282/ https://www.ncbi.nlm.nih.gov/pubmed/35267577 http://dx.doi.org/10.3390/cancers14051269 |
Ejemplares similares
-
DGKζ exerts greater control than DGKα over CD8(+) T cell activity and tumor inhibition
por: Gu, Junchen, et al.
Publicado: (2021) -
DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases
por: Baldanzi, Gianluca, et al.
Publicado: (2019) -
DGK-α keeps integrins close to the edge
por: Mitch, Leslie
Publicado: (2012) -
DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017) -
Identification of Synaptic DGKθ Interactors That Stimulate DGKθ Activity
por: Barber, Casey N., et al.
Publicado: (2022)